Skip to main content

Table 1 Blood exams and gas analysis upon admission and during the two episodes of encephalopathy

From: Severe hepatic encephalopathy in a patient with liver cirrhosis after administration of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker combination therapy: a case report

 

Presentation

After 1st adverse event

After 2nd adverse event

Normal range

AST (U/L)

112

115

137

5-41

ALT (U/L)

71

81

84

7-41

Bilirubin (mg/dL)

1.7

2.8

2.7

<1

Creatinine (mg/dL)

0.8

0.9

0.8

0.7-1.3

Urea (mg/dL)

46

55

50

10-50

Albumin (g/dL)

1.5

1.6

1.6

3.6-4.8

Haemoglobin (g/dL)

9.4

11

10

13-17

WBC (103/μL)

3.9

4.9

5.0

4.0-10.0

Platelets (103/μL)

61

73

78

150.0-450.0

CRP (mg/L)

15

11

12

<5

PT (INR)

1.2

1.2

1.2

0.8-1.2

Na+ (mEq/L)

139

139

140

135-145

K+ (mEq/L)

4.7

5.0

4.2

3.6-5.2

pH

7.43

7.43

7.50

7.35-7.45

HCO3 (mmol/L)

23.6

22.1

24.6

21-23

  1. AST: aspartate aminotransferase; ALT: alanine aminotransferase; WBC: white blood cell; PT: prothrombin time; INR: international normalized ratio; Na+: sodium, K+: potassium, HCO3: bicarbonate.